Publications

FDA Policy Tracker: 2025 Was a Year of Change

Quoted, BioSpace

Hatch-Waxman & Biologics Chair Chad Landmon joins BioSpace to discuss this year’s key FDA policy initiatives impacting the biopharma industry.